EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not need oxygen support and are at risk of severe disease, the European Medicines Agency said in a statement on Friday. The EMA said it had issued its advice to support national authorities who may be keen to deploy the pill, to be branded Lagevrio in Europe, ahead of it gaining full authoristation from the regulator “in light of rising rates of infection and deaths due to COVID-19 across the EU”. The UK’s Medicines and Healthcare products Regulatory Agency recommended at the time that the drug be used as soon as possible following a positive COVID-19 test and within five days of the onset of symptoms, citing clinical data.

Five Days Merck Ema Molnupiravir  european  eu  medicines  pill  drug  regulator  rates  including  ahead  given  emergency  mercks  recommends  covid19  virus

History of this topic

European committee: Regulators should deny Merck’s Lagevrio
1 year, 10 months ago

European committee: Regulators should deny Merck’s Lagevrio

Associated Press  

A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators. A statement from the agency says a committee that has been reviewing Merck’s application for more than a year concluded that the drug’s clinical benefit could not be demonstrated. Merck said in a statement that it …

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 10 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

COVID treatments weren’t suppressed to OK vaccines’ emergency use
54 years, 11 months ago

COVID treatments weren’t suppressed to OK vaccines’ emergency use

Associated Press  

CLAIM: Ivermectin and hydroxychloroquine were suppressed as COVID-19 treatments because the vaccines couldn’t receive emergency use authorization if such treatments were available. THE FACTS: Social media users are sharing a conspiracy theory that posits that the drugs hydroxychloroquine and ivermectin were withheld as COVID-19 treatments by officials in order to greenlight vaccines under emergency use authorization. An emergency use authorization, …

Oral pill for COVID-19 approved by regulator
2 years, 4 months ago

Oral pill for COVID-19 approved by regulator

China Daily  

China Daily| Updated :2022-07-29 China's top drug regulator said on Monday that it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19 disease, adding to the growing medical arsenal against the novel coronavirus. Azvudine, developed by the Genuine Biotech Co based in Henan province, was first conditionally approved to treat HIV-1 infected adult patients …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

Biden admin to promote availability of COVID antiviral pill
2 years, 8 months ago

Biden admin to promote availability of COVID antiviral pill

Associated Press  

WASHINGTON — President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed. A senior administration official said usage of the antiviral regimen has “more than doubled” over the last few weeks, but the administration …

WHO recommends Pfizer's pill Paxlovid for mild Covid cases
2 years, 8 months ago

WHO recommends Pfizer's pill Paxlovid for mild Covid cases

India Today  

The World Health Organisation has strongly recommended nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate Covid-19 patients at highest risk of hospital admission. Pfizer’s oral antiviral drug is strongly recommended for patients with non-severe Covid-19 who are at highest risk of developing severe disease and hospitalisation, such as unvaccinated, older, or immunosuppressed patients. The global health …

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?
2 years, 8 months ago

What is Paxlovid and Who Can Take Pfizer’s Covid-19 Wonder Drug ‘Strongly Recommended’ by WHO?

News 18  

Paxlovid, Pfizer’s Covid-19 antiviral pill, has been “strongly recommended” by the World Health Organization for patients with milder forms of the disease who are still at high risk of hospitalisation. WHO experts have said that Pfizer’s oral treatment prevents hospitalisation more than the “available alternatives, has fewer concerns with respect to harms than Molnupiravir, and is easier to administer than …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 9 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'
2 years, 9 months ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18  

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles
2 years, 9 months ago

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles

LA Times  

Jeff Carlson, a Type 1 diabetic with heart stents, came down with COVID-19 in January, but recovered quickly after being treated with Merck’s molnupiravir. With vaccines and treatments available, “we can make this much more manageable in the future, if people are willing to take care of themselves,” said Dr. Bryan Jarabek, who helps lead COVID-19 treatment and vaccination efforts …

New Biden pandemic plan: Closer to normal for the nation
2 years, 9 months ago

New Biden pandemic plan: Closer to normal for the nation

Associated Press  

WASHINGTON — It’s time for America to stop letting the coronavirus “dictate how we live,” President Joe Biden’s White House declared Wednesday, outlining a strategy to allow people to return to many normal activities safely after two years of pandemic disruptions. A White House official said the “test-to-treat” plan would initially roll out in hundreds of pharmacies across the country, …

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans
2 years, 9 months ago

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans

Firstpost  

In his first State of the Union Address on Tuesday, Biden said thanks to the progress the country has made last year, COVID-19 need no longer controls the lives of the Americans. President Joe Biden has urged Americans to prepare themselves for new coronavirus variants as he launched a new initiative aimed at helping COVID-19-infected people to get tested at …

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan
2 years, 10 months ago

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan

Live Mint  

TOKYO : Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s Paxlovid. Pfizer said its final-stage trial, which included more than 2,000 patients, showed Paxlovid cut the risk of hospitalization or …

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works
2 years, 11 months ago

Health Matters: Don't Feel Guilty About Not Finding Remdesivir for Your Loved One. It Hardly Works

News 18  

It was dinner time when she called for help. They don’t want to use it, but keep it.” Much before the outbreak of second wave, in November 2020, the World Health Organization issued a conditional recommendation against the use of Remdesivir in hospitalised patients, regardless of disease severity saying “there is currently no evidence that Remdesivir improves survival and other …

Cheap version of Merck Covid pill to be made for poorer nations
2 years, 11 months ago

Cheap version of Merck Covid pill to be made for poorer nations

India Today  

A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck & Co's Covid-19 pill molnupiravir for poorer nations, widening access to a drug seen as a weapon in fighting the pandemic. The agreement, negotiated by the UN-backed Medicines Patent Pool with Merck, allows 27 generic drugmakers from India, China and other countries …

WHO adds new drugs to COVID treatments amid Omicron surge
2 years, 11 months ago

WHO adds new drugs to COVID treatments amid Omicron surge

Al Jazeera  

Latest recommendations prompt new calls for patent waivers to allow more people access to treatments. The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids, the UN agency’s panel of international experts said in the guidelines which were published by the British Medical Journal on …

COVID-19 pill rollout stymied by shortages as omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as omicron rages

Associated Press  

WASHINGTON — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator …

COVID-19 pill rollout stymied by shortages as Omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as Omicron rages

LA Times  

A worker handles Paxlovid pills, which are made by Pfizer to treat COVID-19. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator at the University of Pittsburgh Medical Center. “Instead, this feels like the hardest and most chaotic stretch of the pandemic.” The pills — and other …

New Covid-19 pills carry risks: What patients should know
2 years, 11 months ago

New Covid-19 pills carry risks: What patients should know

Live Mint  

The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but they carry safety warnings and limitations that could complicate treatment decisions for patients, doctors and pharmacists. In December, the Food and Drug Administration authorized the use of new pills from Merck & Co., with its partner Ridgeback Biotherapeutics, and Pfizer …

New easy-to-use Covid-19 pills come with a catch. Here's how
2 years, 11 months ago

New easy-to-use Covid-19 pills come with a catch. Here's how

India TV News  

Newly infected COVID-19 patients have two new treatment options that can be taken at home. The pills are intended for those with mild or moderate COVID-19 who are more likely to become seriously ill. That includes older people and those with other health conditions like heart disease, cancer or diabetes that make them more vulnerable. Antiviral pills aren't authorized for …

Age of Omicron, Immunity War & the Endgame: What We May and May Not Avenge in the New Year
3 years ago

Age of Omicron, Immunity War & the Endgame: What We May and May Not Avenge in the New Year

News 18  

The world spent 2020 huddled in shock and 2021 humbled in hope. But as he/she grows up gradually, the body develops immunity and the child does not fall sick often thereafter.” Similarly, as the human body continues to encounter different strains of coronavirus, it will widen the body’s immune response, which, at one point, will make Covid-19 as casual as …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Live updates: Japan approves use of Merck's COVID-19 pill
3 years ago

Live updates: Japan approves use of Merck's COVID-19 pill

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy TOKYO — Japan has approved …

US adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against COVID-19

Associated Press  

WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The FDA authorized Merck’s drug for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. Additionally, …

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

LA Times  

U.S. regulators have authorized a second pill against COVID-19: molnupiravir, an antiviral drug from Merck that may help blunt the wave of coronavirus infections. The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions such as obesity and heart disease. Additionally, …

US adds Merck pill as 2nd easy-to-use drug against Covid-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against Covid-19

India Today  

US health regulators on Thursday authorised the second pill against Covid-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorized Merck's drug for adults with early symptoms of Covid-19 who face the highest risks of hospitalisation, including older people and those with conditions like obesity and heart disease. Additionally, Pfizer's drug …

Merck’s at-home antiviral COVID-19 pill approved by US regulator
3 years ago

Merck’s at-home antiviral COVID-19 pill approved by US regulator

Al Jazeera  

United States health regulators have authorised a second antiviral pill against COVID-19, providing another easy-to-use medication to battle the rising tide of Omicron infections. Additionally, Pfizer’s drug was roughly three times more effective in testing than Merck’s, reducing hospitalisation and death by nearly 90 percent among high-risk patients. Merck’s drug is not authorised for use in patients younger than 18 …

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks
3 years ago

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks

India Today  

As Covid-19 cases peak across the world including the US and the UK, Molnupiravir, an oral drug developed by Merck, could act as a counter. In the phase-III clinical trials, the drug was found to reduce the risk of hospitalisation and death in at-risk, unvaccinated adults, Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory …

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’
3 years ago

Pfizer Covid-19 antiviral pill: Biden says he’s ‘encouraged by the promising data’

CNN  

Washington CNN — President Joe Biden on Tuesday praised Pfizer’s report that its experimental treatment for Covid-19 cut the risk of hospitalization or death by 89% if given to high-risk adults within a few days of their first symptoms. “I am encouraged by the promising data released by Pfizer today, showing that its antiviral pill is effective at reducing the …

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report
3 years ago

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

Hindustan Times  

The government in the United Kingdom is planning to roll out the antiviral pill against Coronavirus disease as part of an offered treatment against the viral disease, according to a report by Sunday Telegraph. The pill -- Molnupiravir -- has been developed by American pharmaceutical company Merck and has been touted as "game-changing" as it can be taken from the …

US panel backs first-of-a-kind COVID-19 pill from Merck
3 years ago

US panel backs first-of-a-kind COVID-19 pill from Merck

Associated Press  

WASHINGTON — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects …

US panel backs Merck's first-of-a-kind Covid-19 pill
3 years ago

US panel backs Merck's first-of-a-kind Covid-19 pill

Hindustan Times  

A panel of US health advisers on Tuesday narrowly backed a closely watched Covid-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during …

US health panel endorses Merck’s COVID-19 pill
3 years ago

US health panel endorses Merck’s COVID-19 pill

Al Jazeera  

If the FDA authorises the drug, it would be the first at-home treatment for COVID-19 two years into the pandemic. He said FDA would have to carefully tailor the drug’s use for patients who stand to benefit most. If the FDA authorises the drug, it would be the first at-home treatment for the virus nearly two years into the pandemic. …

Merck’s covid-19 pill to be reviewed by FDA advisers
3 years ago

Merck’s covid-19 pill to be reviewed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Researchers plan to study molnupiravir and Omicron soon but think the drug could be effective because it has been found to work against other Covid-19 variants, the …

New antiviral drugs are coming for COVID. Here's what you need to know
3 years ago

New antiviral drugs are coming for COVID. Here's what you need to know

NPR  

New antiviral drugs are coming for COVID. Given the higher efficacy of the antibody treatments, "I think we will continue to use those, particularly for high risk people," says Dr. Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital and Harvard Medical School who serves on COVID-19 Treatment Guidelines Panels for the NIH and the Infectious Diseases Society of …

FDA: Merck COVID pill effective, experts will review safety
3 years ago

FDA: Merck COVID pill effective, experts will review safety

Associated Press  

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. Additionally, the FDA flagged a concern that Merck’s drug led to small changes in the coronavirus’ signature spike protein, which it uses to penetrate human cells. …

Merck’s COVID pill shows lower efficacy in updated study
3 years ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

Merck asks EU drug regulator to authorise its Covid-19 pill
3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times  

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir
3 years, 1 month ago

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir

India Today  

Vaccines have been the primary antidote in the battle against Covid-19 to date, but we could have at least two game-changers in the form of American pharmaceutical giant Pfizer's antiviral pill Paxlovid, and Molnupiravir, manufactured by Merck, Sharp and Dohme, and Ridgeback Biotherapeutics. The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 1 month ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Pfizer says Covid-19 pill is 89% effective in preliminary assessment
3 years, 1 month ago

Pfizer says Covid-19 pill is 89% effective in preliminary assessment

Live Mint  

Pfizer Inc. said a preliminary look at study results indicated that its experimental pill was highly effective at preventing people at high risk of severe Covid-19 from needing hospitalization or dying, the latest encouraging performance for an early virus treatment. The company’s drug cut the risk of hospitalization or death in study subjects with mild to moderate Covid-19 by about …

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir
3 years, 1 month ago

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir

India Today  

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain's Medicines and Healthcare products Regulatory Agency recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at …

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%
3 years, 1 month ago

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%

Al Jazeera  

Pharmaceutical companies are in a race to manufacture easy-to-use medication against the coronavirus. Pfizer has said its experimental antiviral pill for COVID-19 cuts risk rates of hospitalisation and death by nearly 90 percent, as drugmakers race to manufacture easy-to-use medication against the coronavirus. Of those given Pfizer’s drug within three days of symptom onset 0.8 percent were hospitalised and none …

UK approves Merck's antiviral COVID pill molnupiravir in world first
3 years, 1 month ago

UK approves Merck's antiviral COVID pill molnupiravir in world first

ABC  

Britain has become the first country in the world to approve Merck's potentially game-changing COVID-19 antiviral pill. Key points: US advisers will meet this month to vote on whether molnupiravir should be authorised Australia has already ordered 300,000 courses Merck is expecting to produce 10 million courses by the end of this year The UK's Medicines and Healthcare products Regulatory …

UK authorizes Merck antiviral pill, 1st shown to treat COVID
3 years, 1 month ago

UK authorizes Merck antiviral pill, 1st shown to treat COVID

Associated Press  

LONDON — Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. The U.S. Food and Drug Administration announced last month it would convene a panel of independent experts to scrutinize the pill’s safety and effectiveness in late November. Merck announced preliminary results in September showing its drug cut hospitalizations and deaths by …

UK becomes first country to approve Merck's anti-Covid pill molnupiravir
3 years, 1 month ago

UK becomes first country to approve Merck's anti-Covid pill molnupiravir

Hindustan Times  

Britain on Thursday approved the use of Merck's antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency announced. Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 1 month ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Britain becomes the first nation to authorize Merck’s COVID-19 pill
3 years, 1 month ago

Britain becomes the first nation to authorize Merck’s COVID-19 pill

LA Times  

So far Merck’s COVID-19 pill is the only one shown to successfully treat the disease. Britain has granted conditional authorization to Merck’s COVID-19 pill — the only one so far shown to successfully treat the disease — becoming the first nation to OK the treatment, although it was not immediately clear how quickly the drug would be available. Merck and …

Discover Related